Protalix BioTherapeutics
PLX
#8648
Rank
HK$0.63 B
Marketcap
HK$8.57
Share price
-4.35%
Change (1 day)
-35.89%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): HK$0.78

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is HK$0.78. In 2022 the company made an earnings per share (EPS) of -HK$2.34 an increase over its 2021 EPS that were of -HK$4.83.

EPS history for Protalix BioTherapeutics from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$0.78-133.5%
2022-HK$2.34-51.61%
2021-HK$4.83342.86%
2020-HK$1.09-88.71%
2019-HK$9.67-34.74%
2018-HK$14.81-70.92%
2017-HK$50.942153.35%
2016-HK$2.26-146.77%
2015HK$4.83-287.88%
2014-HK$2.5710%
2013-HK$2.34130.77%
2012-HK$1.01-56.67%
2011-HK$2.34-46.43%
2010-HK$4.3736.59%
2009-HK$3.2032.26%
2008-HK$2.42-93.4%
2007-HK$36.641298.53%
2006-HK$2.62-96.59%
2005-HK$76.8619.32%
2004-HK$64.411552.65%
2003-HK$3.90-0%
2002-HK$3.90-50%
2001-HK$7.80233.33%
2000-HK$2.34-84.21%
1999-HK$14.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$4.99-740.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$15.28 1,860.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.50 1,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$15.59-2,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel